Pantethine — The Active Form of Vitamin B5 for Lipid Metabolism
Pantethine is the biologically active disulfide form of pantothenic acid (vitamin B5) and the immediate precursor to coenzyme A (CoA). Unlike pantothenic acid, pantethine has demonstrated clinical efficacy for lipid management, reducing total cholesterol, LDL, and triglycerides while raising HDL. It is one of the most evidence-backed natural interventions for dyslipidaemia.
Mechanism of Action
Pantethine is converted to pantetheine and then to 4'-phosphopantetheine, the active component of CoA. CoA is essential for fatty acid synthesis, beta-oxidation, the TCA cycle, and acetylcholine synthesis. Pantethine inhibits HMG-CoA reductase (the same target as statins, but less potently), reduces fatty acid synthesis, and increases fatty acid oxidation. It also has antioxidant effects via cysteamine.
Human Trial Evidence
A 2014 Vascular Health and Risk Management meta-analysis of 28 clinical trials found pantethine (600–900 mg/day) significantly reduced total cholesterol (−14%), LDL (−11%), and triglycerides (−19%) while raising HDL (+8%). A 2011 American Journal of Clinical Nutrition RCT confirmed lipid-lowering effects in low-to-moderate cardiovascular risk patients.
Dosing Protocol
600–900 mg/day in divided doses (300 mg 2–3x/day). Best taken with meals. Effects on lipids seen after 4–8 weeks. Combine with omega-3s and plant sterols for synergistic lipid management. Pantethine is more expensive than pantothenic acid but significantly more bioactive.
Safety & Contraindications
Excellent safety profile. Well-tolerated in all trials. Mild GI effects possible. No significant drug interactions at typical doses. Safe for long-term use. Unlike statins, no myopathy risk.